Company Filing History:
1 out of 1,645 
1 out of 12 
1 out of 116 
Years Active: 2005-2011
Title: The Innovative Mind of Adrian Hobden
Introduction
Adrian Hobden, an accomplished inventor based in Salt Lake City, UT, has made significant contributions to the field of biotechnology with a focus on medical innovations. With a total of three patents to his name, Hobden is recognized for his pioneering work aimed at combating serious health challenges such as HIV and AIDS.
Latest Patents
Hobden’s latest patents reflect his commitment to advancing medical science. One notable invention is an immunizing composition that comprises HIV-1 proviral constructs utilizing an inactive p6 gag TSG101 UEV binding domain. This innovative approach aims to produce budding-defective viral particles that remain tethered to the cell surface, providing valuable methods for both preventing and treating HIV infection and AIDS. Furthermore, he has contributed to the field of coagulation with his invention regarding variants of antithrombin III, where he disclosed compositions and methods related to these variant molecules.
Career Highlights
Hobden's career is marked by his impactful role in institutions that prioritize research and innovation. He has been associated with the University of Utah Research Foundation and Myrexis, Inc., where his work has not only advanced academic research but also driven practical applications in the biomedical field.
Collaborations
Throughout his career, Adrian Hobden has collaborated with distinguished colleagues such as Kenton Zavitz and Scott Morham. These partnerships have contributed to the successful development of his innovative ideas, enriching the collaborative spirit within the scientific community.
Conclusion
Adrian Hobden's inventive contributions highlight the ongoing evolution of medical science and innovation. His dedication to developing novel solutions for critical health issues continues to inspire and influence future research endeavors in the field. With a robust portfolio of patents and collaborative efforts, Hobden stands as a notable figure in the innovation landscape of biotechnology.